What Are the Steps to Prepare Site Personnel for the Adoption of eConsent in Clinical Trials?

A survey found that eConsent can help in recruiting and retaining clinical trial subjects.

A recent study found that site personnel believes that eConsent can help them improve the recruitment and retention of subjects which is critical to the success of clinical trials.

It provided tips for the adoption of eConsent in clinical trials.

These include understanding the execution of study start-up in terms of informed consent and the impact of eConsent on study procedures and related processes.

The next step is identifying information that can be automated by an eConsent solution and ensuring that study staff and participants are properly trained before using eConsent technology.

The eConsent system must be ready for an inspection by a regulatory authority.

It is also important to ensure the protection of clinical trial subjects’ personal and health information.

3 KEY POINTS

  1. Recruitment and retention of subjects are critical to the success of clinical trials but more than 40% of studies fail to meet enrollment goals.
  2. Around 85% of clinical trials fail to retain a sufficient number of subjects, with a 30% average dropout rate.
  3. Sixty-one percent of site personnel felt that eConsent solutions can help in the recruitment of more subjects.

“It’s important to remember that site personnel are not bystanders in the move towards eConsent, but pivotal to developing an eConsent process that benefits all stakeholders in research.” says Sandra “SAM” Sather, Regulatory and Quality Consultant for CRF Health’s TRIALCONSENT electronic informed consent platform.

Article source: http://bit.ly/2VYF3tU
Image source: http://bit.ly/2VS7uK6

#ClinicalTrials, #ClinicalResearch, #eConsent

P.S. Staying up-to-date with what’s new in Clinical Trials? Get the latest articles summarized and delivered free to your e-mail inbox. Click here to learn more.

Latest news

ACTide by Nubilaria against COVID-19

DECEIVER trial for COVID-19 related ARDS intensive care

Read more
Nubilaria ACTide @ Medical device trials

Medical Device Trials – Virtual Experience

Read more
Nubilaria ACTide @ Direct to Patient digital experience

Direct-to-Patient and Virtual Clinical Trials – Digital Experience

Read more

Want more information about our solutions?
Contact us today.

I've read and accept theTerms and Conditions and the Privacy Policy
   I would like to receive information about products and services via traditional mail, telephone, email and automated communication systems